Health

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

September 06, 2025 14:30 ET  | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…

4 weeks ago

Lung Cancer Genetics Study Launches Open-Source Data Platform to Research Community

SAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the…

4 weeks ago

Helios Alliance Announces National Opioid Conference Featuring Former White House Drug Policy Director Dr. Rahul Gupta

September 05, 2025 16:45 ET  | Source: Helios Alliance Mobile, Alabama , Sept. 05, 2025 (GLOBE NEWSWIRE) -- Helios Alliance,…

4 weeks ago

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN:…

4 weeks ago

SAIL signs MoU with The Art of Living to Enhance Employee Well-being, Leadership Belongingness

BENGALURU, India, Sept. 5, 2025 /PRNewswire/ -- Steel Authority of India Limited (SAIL), a Maharatna CPSE, has entered into a…

4 weeks ago

Fitterfly Launches ‘Uplift’ – A Mental Wellness Program for Students and Communities

MUMBAI, India, Sept. 4, 2025 /PRNewswire/ -- A recent national study across nine Indian states covering more than 8,500 college students…

4 weeks ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025

September 04, 2025 20:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05,…

1 month ago

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing…

1 month ago

NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 month ago

Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

LEHI, Utah, Sept. 4, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced…

1 month ago